Heart rate variability patients ventricular arrhythmias effect antiarrhythmic drugs Antiarrhythmic Drug Evaluation Group ADEG purpose study heart rate variability patients ventricular arrhythmias antiarrhythmic drugs study analysis ambulatory electrocardiographic ECG recordings patients frequent complex ventricular arrhythmias Antiarrhythmic Drug Evaluation Group ADEG study recording exclusion premature ventricular complexes number times period consecutive sinus RR intervals ms total count recording index heart rate variability method reliable marker cardiac parasympathetic activity Recordings baseline long-term treatment amiodarone propafenone washout patients presence different number arrhythmias total counts patient reproducible time different recordings Baseline counts median range number arrhythmias antiarrhythmic drugs disparate effect total counts change patients amiodarone median percent change delta NS significant decrease patients flecainide median delta propafenone median delta 